|
1
|
Castleman B and Towne VW: Case records of
the massachusetts general hospital; weekly clinicopathological
exercises; founded by Richard C. Cabot. N Engl J Med. 251:396–400.
1954.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Munshi N, Mehra M, van de Velde H, Desai
A, Potluri R and Vermeulen J: Use of a claims database to
characterize and estimate the incidence rate for Castleman disease.
Leuk Lymphoma. 56:1252–1260. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bucher P, Chassot G, Zufferey G, Ris F,
Huber O and Morel P: Surgical management of abdominal and
retroperitoneal Castleman's disease. World J Surg Oncol.
3(33)2005.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Talat N, Belgaumkar AP and Schulte KM:
Surgery in castleman's disease a systematic review of 404 published
cases. Ann Surg. 255:677–684. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Oksenhendler E, Boutboul D, Fajgenbaum D,
Mirouse A, Fieschi C, Malphettes M, Vercellino L, Meignin V, Gérard
L and Galicier L: The full spectrum of castleman disease: 273
patients studied over 20 years. Br J Haematol. 180:206–216.
2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gopi P, Potty VS, Kaurav RS and Govindan
K: Unicentric Castleman's disease as a localized retroperitoneal
mass: A case report and review of literature. Int J Appl Basic Med
Res. 8:259–262. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Nakata K, Iwahashi N, Matsukawa H, Noguchi
T, Yahata T, Ota N, Mabuchi Y and Ino K: Laparoscopically resected
castleman's disease in the pelvic retroperitoneum: A case report.
Mol Clin Oncol. 12:169–173. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nepal SP, Shichijo T, Ogawa Y, Naoe M,
Oshinomi K and Morita J: Surgical challenges of Castleman's disease
of the pelvis. Urol Case Rep. 34(101518)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kitakaze M, Miyoshi N, Fujino S, Ogino T,
Takahashi H, Uemura M, Mizushima T, Doki Y and Eguchi H: Surgical
resection for pelvic retroperitoneal Castleman's disease: A case
report and review literature. Biomed Rep. 14(29)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Szalat R and Munshi NC: Diagnosis of
castleman disease. Hematol Oncol Clin North Am. 32:53–64.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dispenzieri A, Armitage JO, Loe MJ, Geyer
SM, Allred J, Camoriano JK, Menke DM, Weisenburger DD, Ristow K,
Dogan A and Habermann TM: The clinical spectrum of Castleman's
disease. Am J Hematol. 87:997–1002. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yu LI, Tu M, Cortes J, Xu-Monette ZY,
Miranda RN, Zhang J, Orlowski RZ, Neelapu S, Boddu PC, Akosile MA,
et al: Clinical and pathological characteristics of HIV- and
HHV-8-negative Castleman disease. Blood. 129:1658–1668.
2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Murakami M, Johkoh T, Hayashi S, Ohshima
S, Mizuki M, Nakatsuka SI, Tomobe M, Kuroyanagi K, Nakasone A and
Nishimoto N: Clinicopathologic characteristics of 342 patients with
multicentric Castleman disease in Japan. Mod Rheumatol. 30:843–851.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lomas OC, Streetly M, Pratt G, Cavet J,
Royston D, Schey S and Ramasamy K: British Society for Haematology
(BSH) Committee. The management of Castleman disease. Br J
Haematol. 195:328–337. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yoshizaki K, Matsuda T, Nishimoto N,
Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori
T, et al: Pathogenic signifificance of interleukin-6 (IL-6/BSF-2)
in Castleman's disease. Blood. 74:1360–1367. 1989.PubMed/NCBI
|
|
16
|
Suthaus J, Stuhlmann-Laeisz C, Tompkins
VS, Rosean TR, Klapper W, Tosato G, Janz S, Scheller J and
Rose-John S: HHV-8-encoded viral IL-6 collaborates with mouse IL-6
in the development of multicentric Castleman disease in mice.
Blood. 119:5173–5181. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu AY, Nabel CS, Finkelman BS, Ruth JR,
Kurzrock R, van Rhee F, Krymskaya VP, Kelleher D, Rubenstein AH and
Fajgenbaum DC: Idiopathic multicentric Castleman's disease: A
systematic literature review. Lancet Haematol. 3:e163–e175.
2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Dispenzieri A and Fajgenbaum DC: Overview
of Castleman disease. Blood. 135:1353–1364. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Meador TL and McLarney JK: CT features of
Castleman's disease of the abdomen and pelvis. AJR Am J Roentgenol.
175:115–118. 2000.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jiang Y, Hou G, Zhu Z, Huo L, Li F and
Cheng W: The value of multiparameter 18F-FDG PET/CT
imaging in differentiating retroperitoneal paragangliomas from
unicentric Castleman disease. Sci Rep. 10(12887)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Carbone A, Borok M, Damania B, Gloghini A,
Polizzotto MN, Jayanthan RK, Fajgenbaum DC and Bower M: Castleman
disease. Nat Rev Dis Primers. 7(84)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ren N, Ding L, Jia E and Xue J: Recurrence
in unicentric Castleman's disease postoperatively: A case report
and literature review. BMC Surg. 18(1)2018.PubMed/NCBI View Article : Google Scholar
|
